{
  "0P00000E7S.F": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "FRA",
    "family": "Ibercaja GestiÃ³n SGIIC",
    "long_name": "Ibercaja Sanidad A FI",
    "manager_bio": "",
    "manager_name": "Miriam  FernÃ¡ndez JimÃ©nez",
    "market": "dr_market",
    "short_name": "Ibercaja Sanidad A FI",
    "summary": "La gestiÃ³n toma como referencia la rentabilidad del Ã­ndice 60 % * MSCI World Health Care USD + 35% * MSCI Europe Health Care Index + 5% SimultÃ¡nea mes Zona Euro ExposiciÃ³n, directa o indirectamente (mÃ¡ximo 10% a travÃ©s de IIC), de al menos un 75% en renta variable de empresas dedicadas al cuidado de la salud, incluido equipamiento sanitario, aprovisionamientos sanitarios, distribuidores de productos, proveedores de servicios, gestores y dueÃ±os de instalaciones como hospitales, centros de la 3Âª edad, etc, proveedores de tecnologÃ­a, compaÃ±Ã­as biotecnolÃ³gicas, compaÃ±Ã­as farmaceÃºticas y las relacionadas con otras actividades de investigaciÃ³n, desarrollo y producciÃ³n de fÃ¡rmacos.",
    "total_assets": 481465252.23509216
  },
  "0P00000P3N.F": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "FRA",
    "family": "Novo Banco GestiÃ³n SGIIC",
    "long_name": "NB Pharmafund FI",
    "manager_bio": "",
    "manager_name": "JosÃ© RamÃ³n  Boluda",
    "market": "dr_market",
    "short_name": "NB Pharmafund FI",
    "summary": "La gestiÃ³n toma como referencia el comportamiento del Ã­ndice MSCI New Global Industries World Health. El fondo tendrÃ¡ mÃ¡s del 75% de la exposiciÃ³n total a renta variable, nacional e internacional, de compaÃ±Ã­as relacionadas con el sector de la salud (empresas farmacÃ©uticas, de instrumentos mÃ©dicos, de biotecnologÃ­a, de perfumerÃ­a, de cosmÃ©tica, de seguros sanitarios, etc).El resto de la exposiciÃ³n se alcanzarÃ¡ en renta fija pÃºblica y/o privada (incluidos depÃ³sitos e instrumentos del mercado monetario cotizados o no cotizados que sean lÃ­quidos), sin ninguna limitaciÃ³n por calidad crediticia o duraciÃ³n, pudiendo estar invertido hasta el 25% en activos de baja calidad crediticia (inferior a BBB- segÃºn S&P).",
    "total_assets": 3380997.1924848557
  },
  "0P00000PK1.F": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "FRA",
    "family": "Caixabank Asset Management SGIIC",
    "long_name": "Caixabank Multisalud Estandar FI",
    "manager_bio": "",
    "manager_name": "Jordi  Mas",
    "market": "dr_market",
    "short_name": "Caixabank Multisalud Estandar ",
    "summary": "La gestiÃ³n toma como referencia la rentabilidad del Ã­ndice MSCI World Health Care. Entre el 75% y el 100% de la exposiciÃ³n serÃ¡ en valores de renta variable, cotizados en mercados autorizados, de compaÃ±Ã­as del sector de la salud. Estas inversiones se materializan en valores de baja, media y/o, fundamentalmente, alta capitalizaciÃ³n bursÃ¡til y se dirigen principalmente al mercado americano y europeo complementado con algunas de las compaÃ±Ã­as japonesas mÃ¡s importantes. La inversiÃ³n mÃ¡xima en activos de paÃ­ses emergentes serÃ¡ del 15%. La exposiciÃ³n a riesgo divisa podrÃ¡ superar el 30%.",
    "total_assets": 530165675.01299286
  },
  "0P00000PPN.F": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "FRA",
    "family": "FinanciÃ¨re de l&#39;Arc",
    "long_name": "Arc Actions Sant&#195;&#169; InnovanteA",
    "manager_bio": "",
    "manager_name": "Xavier  d'Ornellas",
    "market": "dr_market",
    "short_name": "Arc Actions Santé InnovanteA",
    "summary": "Lâobjectif de gestion du Fonds vise Ã  obtenir sur la pÃ©riode dâinvestissement recommandÃ©e, une performance nette de frais de gestion supÃ©rieure Ã  celle de lâindice MSCI World Health Care Net Daily Total Return converti en euro pour la part A et en dollar pour la part B. Les dividendes sont rÃ©investis selon la mÃ©thodologie de MSCI (cf. cidessous).",
    "total_assets": 17963443.47785616
  },
  "0P00000QBA.F": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "FRA",
    "family": "Saint Olive Gestion",
    "long_name": "BSO Bio Sant&#195;&#169; C",
    "manager_bio": "",
    "manager_name": "RÃ©my  Plantevin",
    "market": "dr_market",
    "short_name": "BSO Bio Santé C",
    "summary": "Lâobjectif de gestion est la recherche dâune performance supÃ©rieure, sur la durÃ©e de placement recommandÃ©e de cinq ans, Ã  cel le de lâindicateur de rÃ©fÃ©rence, Ã  savoir lâindice MSCI World Health Care en euro, calculÃ© dividendes net rÃ©investis.\nLâindicateur sert de rÃ©fÃ©rence Ã  posteriori : la gestion de lâOPCVM n&#39;Ã©tant pas indicielle, sa performance pourra, le cas Ã©chÃ©ant, s&#39;en Ã©carter sensiblement.",
    "total_assets": 241932744.78716278
  },
  "0P00006HYY.SI": {
    "category": "Sector Equity Healthcare",
    "currency": "SGD",
    "exchange": "SES",
    "family": "UOB Asset Management Ltd",
    "long_name": "UOB United Global Healthcare Fund SGD Acc",
    "manager_bio": "",
    "manager_name": "Not  Disclosed",
    "market": "sg_market",
    "short_name": "United Global Healthcare Fund -",
    "summary": "The investment objective of the Fund is to achieve long term capital growth by investing in securities issued by companies principally involved in the development, production or distribution of products, equipment and/or services related to healthcare, in any part of the world. Such investments would include investing in sub-sectors of the healthcare industry such as medical products, health services, major pharmaceuticals, specialty major pharmaceuticals, and specialty pharmaceuticals.",
    "total_assets": null
  },
  "0P0000HLYB.F": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "FRA",
    "family": "Albemarle Asset Management Ltd",
    "long_name": "Albemarle Longevity Fund Class A",
    "manager_bio": "",
    "manager_name": "Not  Disclosed",
    "market": "dr_market",
    "short_name": "Albemarle Longevity Fund Class",
    "summary": "Albemarle Longevity Fund is an open-end fund incorporated in Ireland. The Fund aims to achieve long term capital appreciation by investing in stocks which could benefit the most from the long-term demographic trend of ageing population. The Fund will have a predominant exposure to Europe.",
    "total_assets": 5180612.732555628
  },
  "0P0000U1SX.F": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "FRA",
    "family": "Albemarle Asset Management Ltd",
    "long_name": "Albemarle Longevity Fund Class I",
    "manager_bio": "",
    "manager_name": "Not  Disclosed",
    "market": "dr_market",
    "short_name": "Albemarle Longevity Fund Class",
    "summary": "Albemarle Longevity Fund is an open-end fund incorporated in Ireland. The Fund aims to achieve long term capital appreciation by investing in stocks which could benefit the most from the long-term demographic trend of ageing population. The Fund will have a predominant exposure to Europe.",
    "total_assets": 5180612.732555628
  },
  "0P0000U2IC.F": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "FRA",
    "family": "Ibercaja GestiÃ³n SGIIC",
    "long_name": "Ibercaja Sanidad B FI",
    "manager_bio": "",
    "manager_name": "Miriam  FernÃ¡ndez JimÃ©nez",
    "market": "dr_market",
    "short_name": "Ibercaja Sanidad B FI",
    "summary": "La gestiÃ³n toma como referencia la rentabilidad del Ã­ndice 60 % * MSCI World Health Care USD + 35% * MSCI Europe Health Care Index + 5% SimultÃ¡nea mes Zona Euro ExposiciÃ³n, directa o indirectamente (mÃ¡ximo 10% a travÃ©s de IIC), de al menos un 75% en renta variable de empresas dedicadas al cuidado de la salud, incluido equipamiento sanitario, aprovisionamientos sanitarios, distribuidores de productos, proveedores de servicios, gestores y dueÃ±os de instalaciones como hospitales, centros de la 3Âª edad, etc, proveedores de tecnologÃ­a, compaÃ±Ã­as biotecnolÃ³gicas, compaÃ±Ã­as farmaceÃºticas y las relacionadas con otras actividades de investigaciÃ³n, desarrollo y producciÃ³n de fÃ¡rmacos.",
    "total_assets": 481465252.23509216
  },
  "0P0000XMSV.L": {
    "category": "Sector Equity Healthcare",
    "currency": "GBp",
    "exchange": "LSE",
    "family": "AXA Investment Managers UK Ltd",
    "long_name": "AXA Framlington Health Fund Z GBP Acc",
    "manager_bio": "",
    "manager_name": "Dani  Saurymper",
    "market": "gb_market",
    "short_name": "AXA Framlington Health Fund Z G",
    "summary": "The aim of this Fund is to provide long-term capital growth. The Fund invests in shares of listed healthcare companies including producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world albeit the Fund tends to be biased towards the US, as this is where the majority of healthcare related companies are based. The Manager selects shares based upon analysis of a companyâs financial status, quality of its management, expected profitability and prospects for growth.",
    "total_assets": null
  },
  "0P0000XTT7.F": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "FRA",
    "family": "Trecento Asset Management",
    "long_name": "Trecento Sant&#195;&#169; ISR R EUR",
    "manager_bio": "",
    "manager_name": "Alice  Lhabouz",
    "market": "dr_market",
    "short_name": "Trecento Santé ISR R EUR",
    "summary": "Trecento SantÃ© ISR est un fonds qui investit en actions de sociÃ©tÃ©s internationales issues du secteur de la santÃ© (notamment les laboratoires pharmaceutiques, les biotechnologies, le matÃ©riel mÃ©dical, les services de santÃ©) et ce sans rÃ©fÃ©rence Ã  un indice. Le fonds Trecento SantÃ© ISR a pour objectif dâoffrir une performance annuelle supÃ©rieure Ã  7% nette de frais pour les parts Â« R EUR Â», Â« R CHF Â» et Â« R USD Â» et supÃ©rieure Ã  8% nette de frais pour la part Â« I EUR Â». Cet objectif de performance est associÃ© Ã  un objectif de gestion extra-financier visant Ã  exclure les sociÃ©tÃ©s aux pratiques ESG (Environnement, Social, Gouvernance) contestables (via une politique dâexclusion normative et sectorielle) et Ã  sÃ©lectionner les sociÃ©tÃ©s affichant les meilleures pratiques ESG â approche Â« best-in-class Â».",
    "total_assets": null
  },
  "0P000156VT.F": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "FRA",
    "family": "Axxion S.A.",
    "long_name": "nova Steady HealthCare P",
    "manager_bio": "",
    "manager_name": "Not  Disclosed",
    "market": "dr_market",
    "short_name": "nova Steady HealthCare P",
    "summary": "n/a",
    "total_assets": 45551338.879984856
  },
  "0P00015JIF.F": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "FRA",
    "family": "INKA Internationale KAG mbH",
    "long_name": "apo Medical Opportunities Institutionell",
    "manager_bio": "",
    "manager_name": "Kai  BrÃ¼ning",
    "market": "dr_market",
    "short_name": "apo Medical Opportunities Insti",
    "summary": "n/a",
    "total_assets": 136235118.74507904
  },
  "0P00016BB7.HK": {
    "category": "Sector Equity Healthcare",
    "currency": "HKD",
    "exchange": "HKG",
    "family": "BOCI-Prudential Asset Management Ltd",
    "long_name": "BOCIP China Health Care Fund A",
    "manager_bio": "",
    "manager_name": "Not  Disclosed",
    "market": "hk_market",
    "short_name": "BOCIP China Health Care Fund A",
    "summary": "The Sub-Fund seeks to provide investors with long-term capital appreciation by investing in securities that design, make or sell products and services related to health care industry in the Peopleâs Republic of China (âPRCâ). Such theme-specific securities include companies in the PRC (i) that are engaged in pharmaceuticals, biotechnology, medical devices or technology,surgical research or equipment, healthcare provision and consultation, health or nutrition\nsupplements research or production, ownership and/or management of or provision of services relating to hospitals, nursing homes or health maintenance organizations, infancy care centres or after-life service organizations; or (ii) companies having their major business activities related or connected to healthcare sector.",
    "total_assets": 403813.6183257103
  },
  "0P00017IUO.F": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "FRA",
    "family": "Caixabank Asset Management SGIIC",
    "long_name": "Caixabank Multisalud Premium FI",
    "manager_bio": "",
    "manager_name": "Jordi  Mas",
    "market": "dr_market",
    "short_name": "Caixabank Multisalud Premium FI",
    "summary": "La gestiÃ³n toma como referencia la rentabilidad del Ã­ndice MSCI World Health Care. Entre el 75% y el 100% de la exposiciÃ³n serÃ¡ en valores de renta variable, cotizados en mercados autorizados, de compaÃ±Ã­as del sector de la salud. Estas inversiones se materializan en valores de baja, media y/o, fundamentalmente, alta capitalizaciÃ³n bursÃ¡til y se dirigen principalmente al mercado americano y europeo complementado con algunas de las compaÃ±Ã­as japonesas mÃ¡s importantes. La inversiÃ³n mÃ¡xima en activos de paÃ­ses emergentes serÃ¡ del 15%. La exposiciÃ³n a riesgo divisa podrÃ¡ superar el 30%.",
    "total_assets": 530165675.01299286
  },
  "0P00017IVH.F": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "FRA",
    "family": "Caixabank Asset Management SGIIC",
    "long_name": "Caixabank Multisalud Plus FI",
    "manager_bio": "",
    "manager_name": "Jordi  Mas",
    "market": "dr_market",
    "short_name": "Caixabank Multisalud Plus FI",
    "summary": "La gestiÃ³n toma como referencia la rentabilidad del Ã­ndice MSCI World Health Care. Entre el 75% y el 100% de la exposiciÃ³n serÃ¡ en valores de renta variable, cotizados en mercados autorizados, de compaÃ±Ã­as del sector de la salud. Estas inversiones se materializan en valores de baja, media y/o, fundamentalmente, alta capitalizaciÃ³n bursÃ¡til y se dirigen principalmente al mercado americano y europeo complementado con algunas de las compaÃ±Ã­as japonesas mÃ¡s importantes. La inversiÃ³n mÃ¡xima en activos de paÃ­ses emergentes serÃ¡ del 15%. La exposiciÃ³n a riesgo divisa podrÃ¡ superar el 30%.",
    "total_assets": 530165675.01299286
  },
  "0P0001J72Z.F": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "FRA",
    "family": "Renta 4 Gestora SGIIC S.A.",
    "long_name": null,
    "manager_bio": "",
    "manager_name": "",
    "market": "dr_market",
    "short_name": "Renta 4 Megatendencias Salud, I",
    "summary": "La exposiciÃ³n a renta variable serÃ¡ como mÃ­nimo del 75%, exclusivamente en empresas relacionadas con el sector de cuidados de la salud, que incluye los sub-sectores biotecnolÃ³gico, farmacÃ©utico, equipos mÃ©dicos, gestiÃ³n de la salud, cosmÃ©tica, asÃ­ como en empresas de servicios, distribuciÃ³n, suministros, instalaciones o herramientas vinculados a dichos sectores, todo ello sin lÃ­mite en tÃ©rminos de distribuciÃ³n geogrÃ¡fica ni capitalizaciÃ³n, por lo que se podrÃ¡ invertir en compaÃ±Ã­as de baja, mediana y elevada capitalizaciÃ³n bursÃ¡til.",
    "total_assets": 11462601.406667233
  },
  "LSP.AS": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "AMS",
    "family": "Life Sciences Partners",
    "long_name": "LSP Life Sciences Fund N.V.",
    "manager_bio": "",
    "manager_name": "Mark  Wegter",
    "market": "nl_market",
    "short_name": "LSP LIFE SCIENCES",
    "summary": "The Fund&#39;s primary investment objective is to achieve capital appreciation by investing in a diversified, yet concentrated portfolio of publicly listed life sciences companies (including biopharmaceutical-, specialist pharmaceutical-, medical device-, drug delivery-, vaccine- and diagnostic companies). The majority of the Fundâs portfolio will consist of European and American companies listed on one of the (main) stock exchanges, with a market capitalization of below EUR 2.5 billion at the time of investment.",
    "total_assets": 67283984.91769886
  },
  "SELJLP.MI": {
    "category": "Sector Equity Healthcare",
    "currency": "EUR",
    "exchange": "MIL",
    "family": "SELECTRA MANAGEMENT COMPANY S.A.",
    "long_name": "Selectra Investments Sicav - J Lamarck Pharma D",
    "manager_bio": "",
    "manager_name": "",
    "market": "it_market",
    "short_name": "SELECTRA J. LAMARCK PHARMA CLAS",
    "summary": "The main objective of this Sub-Fund is to profit from increasing share prices in the pharmaceutical sector worldwide. The focus is on mature top tier pharmaceutical companies and companies with interesting pipeline of products in development in a single or numerous markets. The followed investment policy will enable the Sub-Fund to increase overall return by active stock selection of companies, offering the most promising technology platform.",
    "total_assets": 11281489.025491476
  }
}
